Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar 27;19(1):52.
doi: 10.1186/s12931-018-0752-9.

Oxidative stress enhances the expression of IL-33 in human airway epithelial cells

Affiliations

Oxidative stress enhances the expression of IL-33 in human airway epithelial cells

Hiroyuki Aizawa et al. Respir Res. .

Erratum in

Abstract

Background: Interleukin-33 (IL-33) is a cytokine belonging to the IL-1 family, and its possible involvement in the pathophysiology of COPD and viral-induced exacerbations has been demonstrated. IL-33 has been shown to be increased in the airway epithelial cells from COPD patients, but the regulating mechanism of IL-33 expression in airway epithelial cells remains largely unknown. In the current study, we examined whether oxidative stress, which participates in the pathogenesis of COPD, affects the expression of IL-33 in airway epithelial cells and also evaluated the effect during viral infection.

Methods: The involvement of oxidative stress in the expression of IL-33, and its signal pathway was examined after stimulation with hydrogen peroxide (H2O2), with or without stimulation by polyinosinic-polycytidylic acid [poly (I:C)], a synthetic analogue of dsRNA that mimics viral infection, or rhinovirus infection in NCI-H292 cells and primary human bronchial epithelial cells (HBECs). In addition, the effect of antioxidant, N-acetylcysteine (NAC) in the expression of IL-33 was compared between HBECs from healthy subjects and those from COPD patients.

Results: Treatment with H2O2 significantly potentiated IL-33 expression in NCI-H292 cells, and the potentiation was reversed by NAC treatment. Mitogen-activated protein kinase (MAPK) inhibitors, but not nuclear factor-kappa B inhibitors, also significantly decreased the H2O2-potentiated IL-33 expression. In addition, H2O2 significantly potentiated the poly (I:C)- or rhinovirus-stimulated IL-33 expression. In HBECs from healthy subjects, H2O2-potentiated IL-33 expression and its reversal by NAC was also confirmed. Under the condition without H2O2-stimulation, treatment with NAC significantly decreased the expression of IL-33 in HBECs from COPD patients, but not in those from healthy subjects.

Conclusions: These results demonstrate that oxidative stress involves in the expression of IL-33 in airway epithelial cells via MAPK signal pathway and it augments IL-33 expression during viral infection. This mechanism may participate in the regulation of IL-33 expression in airway epithelial cells in COPD and the viral-induced exacerbations. Modulation of this pathway could become a therapeutic target for viral-induced exacerbations of COPD.

Keywords: COPD; Exacerbation; IL-33; Oxidative stress; Viral infection.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

All experiments in the study were approved by ethics committee of Tohoku University Graduate School of Medicine and written informed consent was obtained from all participating patients.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing of interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Effect of H2O2 on the expression of Interleukin-33 (IL-33) in NCI-H292 cells. a-c Effect of H2O2 on the gene expression of IL-33 and the cell viability in NCI-H292 cells. a, b Cells were treated with various concentration of H2O2. After 4 h incubation, whole cells were harvested and assayed for the gene expression of IL-33 (a) and cell viability (b). c Cells were treated with 200 μM H2O2. At various time points after the incubation, whole cells were harvested and assayed. d, e Evaluation of nuclear fraction of IL-33 protein. At various time points after the treatment with 200 μM H2O2, the nuclear fraction of cell lysates was obtained. d IL-33 protein in the nuclear fraction was evaluated by immunoblotting. e Each band intensity was assessed by densitometry. Relative intensity was calculated by dividing the IL-33 band intensity by each appropriate lamin A/C band intensity. f Effect of N-acethylcysteine (NAC) on H2O2-augmented IL-33 expression. Values are the mean ± SEM (n = 3 - 5). *p < 0.05, ***p < 0.001 compared with the values of vehicle-treated cells
Fig. 2
Fig. 2
Involvement of mitogen-activated protein kinase signaling pathways in H2O2-potentiated IL-33 expression. a-d Effect of H2O2 on the phosphorylation of MAPK (p38, JNK, ERK1/2) in NCI-H292 cells. Cells were treated with NAC or vehicle prior to treatment with H2O2. After 15 min, whole cell lysates were obtained. a Phosphorylation of p38, JNK or ERK was evaluated with immunoblotting. b-d Band intensities were assessed by densitometry. Relative intensity was calculated by dividing the phosphorylated p38, JNK or ERK1/2 band intensity by the p38, JNK or ERK1/2 band intensity and the results were indicated as fold change over control. e-g Effect of p38-MAPK inhibitor (SB203580) (e), JNK inhibitor (SP600125) (f) or ERK inhibitor (U0126) (g) on H2O2-potentiated IL-33 expression in NCI-H292 cells. Values are the mean ± SEM (n = 3). **p < 0.01, ***p < 0.001 compared with the values of vehicle-treated cells
Fig. 3
Fig. 3
Effect of H2O2 on a synthetic viral dsRNA analogue, poly (I:C)-potentiated IL-33 expression. a NCI-H292 cells were treated with H2O2 or vehicle 30 min prior to the treatment with poly (I:C). After 4 h, whole cells were harvested and assayed for the IL-33 gene expression. b Effect of NAC on H2O2-augmented IL-33 expression in poly (I:C)-treated cells. Cells were added with NAC before H2O2 treatment, and then treated with poly (I:C). Values are the mean ± SEM (n = 3 - 4). ***p < 0.001 compared with the values of vehicle-treated control. †††p < 0.001 compared with the values of poly (I:C)-treated control
Fig. 4
Fig. 4
Effect of H2O2 on viral-potentiated IL-33 expression. Time course (a) or comparison at 4 and 24 h (b) of IL-33 expression after treatment with H2O2 and human rhinovirus, RV14 infection. NCI-H292 cells were infected with RV14 in the presence of H2O2 or vehicle. At various time points after incubation (a) or after 4 and 24 h (b), whole cells were harvested and assayed for the IL-33 gene expression. c Effect of NAC on H2O2-augmented IL-33 expression in RV14-treated cells. Cells were added with NAC before H2O2 treatment, and then infected with RV14. After 24 h RV14 infection, whole cells were harvested and assayed. Values are the mean ± SEM (n = 2 - 5). *p < 0.05, **p < 0.01, ***p < 0.001 compared with the values of vehicle-treated cells
Fig. 5
Fig. 5
Involvement of oxidative stress in the expression of IL-33 in HBECs from COPD patients. a Effect of H2O2-potentiated IL-33 expression and reversal by NAC in human bronchial epithelial cells (HBECs) from healthy subjects. Cells were treated with NAC or vehicle prior to treatment with H2O2. After 4 h, whole cells were harvested and assayed for the IL-33 gene expression. b Effect of NAC on the expression of IL-33 in HBECs from healthy subjects and COPD patients. Cells were treated with NAC or vehicle. After 4 h, whole cells were harvested and assayed. The data are expressed as the mean ± SEM of five healthy subjects or six COPD patients. c-e Effect of p38-MAPK inhibitor (SB203580), JNK inhibitor (SP600125) or ERK inhibitor (U0126) on the expression of IL-33 in HBECs from COPD patients. Cells were treated with the MAPK inhibitor or vehicle. After 4 h, whole cells were harvested and assayed. The data is a representative of two independent experiments with four samples performed using HBECs from two COPD patients. **p < 0.01 compared with the values of vehicle-treated cells
Fig. 6
Fig. 6
Schematic representation of the effect of oxidative stress on IL-33 expression in airway epithelial cells. H2O2 potentiates the expression of IL-33 in human airway epithelial cells. H2O2 enhances the phosphorylation of MAPK (p38, JNK, ERK1/2) and a p38 MAPK inhibitor, SB203580, a JNK inhibitor, SP600125, and an ERK1/2 inhibitor, U0126 inhibits the expression of IL-33. Neither an IKK-2 inhibitor, SC-514 nor an IκBα inhibitor, BAY11-7085 affects the H2O2-augmented IL-33 expression. H2O2 potentiates the expression of IL-33 stimulated by TLR3 ligand, poly (I:C) and rhinoviral-infection, and the potentiation is inhibited by the antioxidant NAC. These data suggest that oxidative stress enhances the expression of IL-33 via MAPK pathway and the expression of IL-33 can be further increased in human airway epithelial cells during virus infections. NAC = N-acetylcysteine. BAY = BAY 11-7085

References

    1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380:2095–2128. doi: 10.1016/S0140-6736(12)61728-0. - DOI - PMC - PubMed
    1. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57:847–852. doi: 10.1136/thorax.57.10.847. - DOI - PMC - PubMed
    1. Kanner RE, Anthonisen NR, Connett JE. Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med. 2001;164:358–364. doi: 10.1164/ajrccm.164.3.2010017. - DOI - PubMed
    1. Miravitlles M, Murio C, Guerrero T, Gisbert R, et al. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest. 2002;121:1449–1455. doi: 10.1378/chest.121.5.1449. - DOI - PubMed
    1. Connors AF, Jr, Dawson NV, Thomas C, Harrell FE, Jr, Desbiens N, Fulkerson WJ, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (study to understand prognoses and preferences for outcomes and risks of treatments) Am J Respir Crit Care Med. 1996;154:959–967. doi: 10.1164/ajrccm.154.4.8887592. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources